SPNT completes $250 million ArmadaCorp Capital divestiture to Ambac

Rhea-AI Filing Summary

SiriusPoint Ltd. completed the previously announced sale of all membership interests in ArmadaCorp Capital, LLC, the holding company of its supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc.

The Seller received $250 million in cash consideration, subject to deductions including transaction expenses. The transaction closed after satisfaction of customary closing conditions.

Insights

Insurance M&A analyst

SiriusPoint closed a $250M cash asset sale to Ambac.

SiriusPoint finalized the divestiture of ArmadaCorp Capital, which holds ArmadaCare, to an Ambac subsidiary. The Seller received cash consideration of $250,000,000, subject to deductions such as transaction expenses. Closing followed customary conditions, indicating a standard process.

The filing states the consideration and counterparties but does not detail use of proceeds or strategic redeployment. Actual financial impact depends on deductions and any subsequent capital actions disclosed elsewhere.

SiriusPoint Ltd false 0001576018 0001576018 2025-10-31 2025-10-31 0001576018 us-gaap:CommonStockMember 2025-10-31 2025-10-31 0001576018 us-gaap:SeriesBPreferredStockMember 2025-10-31 2025-10-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): November 3, 2025 (October 31, 2025)

SIRIUSPOINT LTD.

(Exact name of registrant as specified in its charter)

Bermuda		001-36052		98-1599372
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

Point Building

3 Waterloo Lane

Pembroke HM 08 Bermuda

(Address of principal executive offices and Zip Code)

Registrant’s telephone number, including area code: +1 441 542-3300

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol(s)		Name of each exchange on which registered
Common Shares, $0.10 par value		SPNT		New York Stock Exchange
8.00% Resettable Fixed Rate Preference Shares, Series B, $0.10 par value, $25.00 liquidation preference per share		SPNT PB		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On October 31, 2025, a subsidiary of SiriusPoint Ltd. (the “Company”) completed the previously announced sale of all of the issued and outstanding limited liability company membership interests in ArmadaCorp Capital, LLC (“Armada”), the holding company of the Company’s wholly owned supplemental health insurance program manager, ArmadaCare, to a subsidiary of Ambac Financial Group Inc. (“Ambac”), pursuant to the Membership Interest Purchase Agreement (the “Purchase Agreement”), dated September 29, 2025, by and among Sirius Acquisitions Holding Company (“Seller”), Cirrata VI, LLC, and, solely for the limited purposes set forth therein, Sirius Re Holdings, Inc. and Ambac.

Under the terms of the Purchase Agreement, Seller received cash consideration of $250 million, subject to certain deductions, including transaction expenses. The transaction closed following the satisfaction of customary closing conditions.

Item 9.01.  Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				SIRIUSPOINT LTD.
Date: November 3, 2025				By:		/s/ Linda S. Lin
						Name: Linda S. Lin
						Title:  Chief Legal Officer and Corporate Secretary

FAQ

What did SPNT announce in this 8-K?

SiriusPoint completed the sale of all membership interests in ArmadaCorp Capital, LLC, the holding company of ArmadaCare, to an Ambac subsidiary.

What was the consideration for the Armada sale by SPNT?

The Seller received $250 million in cash consideration, subject to deductions including transaction expenses.

Who is the buyer of ArmadaCorp Capital from SPNT (SPNT)?

A subsidiary of Ambac Financial Group Inc. purchased the membership interests.

When did SiriusPoint (SPNT) close the Armada transaction?

The transaction closed on October 31, 2025, after satisfaction of customary closing conditions.

What businesses were included in the SPNT transaction?

The sale covered all issued and outstanding membership interests in ArmadaCorp Capital, LLC, the holding company for ArmadaCare.

Does SiriusPoint disclose how it will use the $250 million?

The filing specifies the $250 million cash consideration, subject to deductions, but does not state use of proceeds.